Suppr超能文献

在单一机构进行290例胰腺移植的10年经验。

A 10-year experience with 290 pancreas transplants at a single institution.

作者信息

Sutherland D E, Dunn D L, Goetz F C, Kennedy W, Ramsay R C, Steffes M W, Mauer S M, Gruessner R, Moudry-Munns K C, Morel P

机构信息

Department of Surgery, University of Minnesota Hospital, Minneapolis 55455.

出版信息

Ann Surg. 1989 Sep;210(3):274-85; discussion 285-8. doi: 10.1097/00000658-198909000-00003.

Abstract

Since our report at the 1984 American Surgical Association meeting of 100 pancreas transplants from 1966 through 1983, another 190 have been performed. The current series, begun in 1978, now numbers 276 cases, and includes 133 nonuremic recipients of pancreas transplants alone (PTA), 46 simultaneous pancreas/kidney transplants (SPK), and 97 pancreas tranplants after a kidney transplant (PAK). Duct management techniques used were free intraperitoneal drainage in 44 cases, duct occlusion in 44, enteric drainage in 89, and bladder drainage in 128. The 1-year patient and graft survival rates in the entire cohort of 276 were 91% and 42%. One-year patient survival rates were 88% in the first 100, 91% in the second 100, and 92% in the last 76 cases; corresponding 1-year graft survival rates were 28%, 47%, and 56% (p less than 0.05). A prospective comparison of bladder drainage (n = 82) versus enteric drainage (n = 46) in PAK/PTA cases since November 1, 1984 favored bladder drainage (1-year graft survival rates of 52% vs. 41%) because of urinary amylase monitoring. The best results were in recipients of primary SPK bladder-drained transplants (n = 39), with a 1-year pancreas graft survival rate of 75%, kidney graft survival rate of 80%, and patient survival rate of 95%. Logistic regression analysis, with 1-year graft function as the independent variable, showed significant (p less than 0.05) predictors of success (odds ratio) to be technique: bladder drainage (5.8) versus enteric drainage (2.5) versus duct injection (1.0); category: SPK (6.0) versus PAK from same donor (3.2) versus PAK from different donor (1.2) versus PTA (1.0); and donor HLA DR mismatch: 0 (5.0) versus 1 (2.5) versus 2 (1.0) antigens. On April 1, 1989, 90 patients had functioning grafts (60 euglycemic and insulin-free for more than 1 year, 10 for 5 to 10 years); these, along with 24 others whose grafts functioned for 1 to 6 years before failing, are part of an expanding cohort in whom the influence of inducing a euglycemic state on pre-existing secondary complications of diabetes is being studied. Only preliminary data is available. In regard to neuropathy, at more than 1 year after transplant in patients with functioning grafts, conduction velocities in some nerves were increased over baseline. In regard to retinopathy, deterioration in grade occurred in approximately 30% of the recipients by 3 years, whether the graft functioned continuously or failed early, but thereafter retinopathy in the patients with functioning grafts remained stable.(ABSTRACT TRUNCATED AT 400 WORDS)

摘要

自我们在1984年美国外科协会会议上报告了1966年至1983年期间的100例胰腺移植情况以来,又进行了190例移植手术。始于1978年的当前系列病例现达276例,包括133例仅接受胰腺移植(PTA)的非尿毒症受者、46例胰肾联合移植(SPK)以及97例肾移植后胰腺移植(PAK)。所采用的导管处理技术包括44例的游离腹腔内引流、44例的导管闭塞、89例的肠道引流以及128例的膀胱引流。276例患者的1年患者和移植物存活率分别为91%和42%。前100例患者的1年患者存活率为88%,第二个100例为91%,最后76例为92%;相应的1年移植物存活率分别为28%、47%和56%(p小于0.05)。自1984年11月1日起对PAK/PTA病例中膀胱引流(n = 82)与肠道引流(n = 46)进行的前瞻性比较显示,由于尿淀粉酶监测,膀胱引流更具优势(1年移植物存活率分别为52%和41%)。最佳结果见于初次接受膀胱引流的SPK移植受者(n = 39),其1年胰腺移植物存活率为75%,肾移植物存活率为80%,患者存活率为95%。以1年移植物功能作为自变量的逻辑回归分析显示,成功的显著(p小于0.05)预测因素(优势比)为技术:膀胱引流(5.8)、肠道引流(2.5)、导管注射(1.0);类别:SPK(6.0)、来自同一供体的PAK(3.2)、来自不同供体的PAK(1.2)、PTA(1.0);以及供体HLA DR错配:0个抗原(5.0)、1个抗原(2.5)、2个抗原(1.0)。1989年4月1日,90例患者的移植物功能良好(60例血糖正常且无需胰岛素超过1年,10例达5至10年);这些患者以及另外24例移植物在功能1至6年后失功的患者,构成了一个不断扩大的队列,正在研究诱导血糖正常状态对糖尿病已存在的继发性并发症的影响。目前仅有初步数据。关于神经病变,在移植物功能良好的患者移植后1年以上,一些神经的传导速度较基线有所增加。关于视网膜病变,到3年时,约30%的受者病情分级出现恶化,无论移植物是持续功能良好还是早期失功,但此后移植物功能良好的患者视网膜病变保持稳定。(摘要截取自400字)

相似文献

1
A 10-year experience with 290 pancreas transplants at a single institution.在单一机构进行290例胰腺移植的10年经验。
Ann Surg. 1989 Sep;210(3):274-85; discussion 285-8. doi: 10.1097/00000658-198909000-00003.

引用本文的文献

1
Pancreas transplantation.胰腺移植。
Gut Liver. 2010 Dec;4(4):450-65. doi: 10.5009/gnl.2010.4.4.450. Epub 2010 Dec 17.
6
Duodenal segment complications in vascularized pancreas transplantation.血管化胰腺移植中的十二指肠段并发症
J Gastrointest Surg. 1997 Nov-Dec;1(6):534-44. doi: 10.1016/s1091-255x(97)80070-4.
7
Pancreas transplantation.胰腺移植
Int J Pancreatol. 1995 Feb;17(1):1-13. doi: 10.1007/BF02788353.

本文引用的文献

2
UREMIA--NATURE'S IMMUNOSUPPRESSIVE DEVICE.尿毒症——自然的免疫抑制机制。
Ann Intern Med. 1965 Jan;62:166-70. doi: 10.7326/0003-4819-62-1-166.
8
One hundred pancreas transplants at a single institution.单一机构的一百例胰腺移植手术。
Ann Surg. 1984 Oct;200(4):414-40. doi: 10.1097/00000658-198410000-00004.

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验